AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

MEDISCA Promotes Efficiency and Quality Control with New Patent for Planetary Mixers

February 5, 2020 GMT

MONTREAL--(BUSINESS WIRE)--Feb 4, 2020--

MEDISCA Pharmaceutique Inc. (“MEDISCA”), a global leader of innovative products and services for the pharmaceutical compounding industry, is pleased to announce the issuance of United States Patent 10,420,705, covering an adapter for use in planetary mixers. This adapter is useful for those seeking the benefits of high homogeneity and short mixing time afforded by a rotation-revolution mixer, while keeping the final mixed product in the same dispenser that pharmacists, for example, will use in their regular compounding activities.

MEDISCA’s innovative and ongoing contributions in the field of pharmaceutical compounding is reflected in this additional issued patent in its global patent portfolio. Some of these proprietary improvements and innovations, including U.S. Patents 10,420,705 and 10,231,903, cover uses and functionalities of the MAZ™, the successful brand of a high-performance planetary mixer used in an increasing number of compounding pharmacies worldwide and is available exclusively through MEDISCA.

“If we discover that our clients are struggling with a specific process, we go to work finding innovative solutions to fit their needs”, said Panagiota Danopoulos, Senior Director at MEDISCA. “We are dedicated to not only providing the highest quality ingredients for medications, but ensuring that each step of the compounding process is safe and effective for those we serve.”

MEDISCA continues to grow its intellectual property portfolios in Canada, U.S.A and globally in its key commercial markets. MEDISCA will continue its vigilance in the pharmaceutical compounding industry in order to protect its numerous innovative products and services, as well as the significant investments the company makes in research and development, marketing and its patent and trademark portfolios globally.

View source version on businesswire.com:https://www.businesswire.com/news/home/20200204006104/en/

CONTACT: Alphée Beauchamp

6090 Henri-Bourassa Blvd W, Saint-Laurent, Quebec H4R 3A6, Canadaabeauchamp@medisca.com

(514) 333-7811 x1230

KEYWORD: NORTH AMERICA CANADA

INDUSTRY KEYWORD: PHARMACEUTICAL HEALTH MEDICAL SUPPLIES MEDICAL DEVICES

SOURCE: MEDISCA Pharmaceutique Inc.

Copyright Business Wire 2020.

PUB: 02/04/2020 08:47 PM/DISC: 02/04/2020 08:47 PM

http://www.businesswire.com/news/home/20200204006104/en